Mytide Therapeutics

Manufacturing custom peptides for researchers.

Launch date

Sep 2018

Employees

Market cap

Enterprise valuation

Boston Massachusetts (HQ)

Date	Investors	Amount	Round
-	Creative Destruction Lab Beresford Ventures Small Business Innovation Research (SBIR)	N/A	-
Sep 2019	Massachusetts Life Sciences Center	$200k	Grant
Jan 2020	Massachusetts Life Sciences Center National Science Foundation	$430k	Grant
Jan 2021	Uncommon Denominator	N/A	-
Mar 2022*	Uncommon Denominator Alloy Therapeutics	$7.0m	Series A
Total Funding		€6.9m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Mytide Therapeutics